Drug design and discovery ppt

NEETHUSASOKAN 16,404 views 19 slides Dec 04, 2019
Slide 1
Slide 1 of 19
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19

About This Presentation

Drugs and design a drug


Slide Content

A short
Introduction to
Drug design and
discovery
neethu asokan

What is a drug?
•Defined composition with a pharmacological effect
•Regulated by the Food and Drug Administration (FDA)
•What is the process of Drug Discovery and Development?
neethu asokan

Drug designing
1)challenging
2)Expensive
3)Time consuming
So, Multidisciplinary approach:
Computational tools, methodologies for structure guided
approach + Global gene expression data analysis by
softwares.
Hence,
1)Efficiency increased
2)Cost effectiveness
3)Time saved
4)Strategies to overcome toxic side effects
neethu asokan

Drug design
Hence,
1)Efficiency increased
2)Cost effectiveness
3)Time saved
4)Strategies to overcome toxic side effects
neethu asokan

DRUG DESIGN
2 ways:
A)Development of ligands with desired properties
for targets having known structure and functions.
B)Development of ligands with predefined
properties for targets whose structural
information may be or may not be known.
This, unknown target information can be found by
global gene expression data.
neethu asokan

How drugs are taken?
Inhaled
Injection
Orally
Snorted
Transdermal (Patches)
Through body orifices
neethu asokan

A Little History of Computer
Aided Drug Design
•1960’s -Viz -review the target -drug interaction
•1980’s-Automation -high trhoughput target/drug selection
•1980’s-Databases (information technology) -combinatorial
libraries
•1980’s-Fast computers -docking
•1990’s-Fast computers -genome assembly -genomic based
target selection
•2000’s-Vast information handling -pharmacogenomics
neethu asokan

Drug Designing Methods:
•Databases:
PDB: Experimentally determined structures.
NCI: National Cancer Institute.
Pubchem: Bulk data available for QSAR for lead discovery.
3D MIND: Information about cytotoxicpotency for 60 human cancer
cell lines.
OSIRIS: To draw chemical structures and predict drug like properties
like absorption in body etc.
Links at the bottom of the paper.
Autodockand Dock6 for docking
neethu asokan

Toxicity
•Toxicologyis the study of toxic effects of drugs or
other substances on the body
•Physicians must weigh therapeutic benefit against the
risk of toxicity
•Some drugs have a narrow therapeutic-toxic index
called the “therapeutic window”
•very little difference exists in the therapeutic versus toxic
blood level
•laboratory drug levels are ordered if the physician suspects
toxicity
•Toxicity of a drug may affect route of administration
neethu asokan

Discovery and Development
•The time from conception to approval of a new drug is
typically 10-15 years
•The vast majority of molecules fail along the way
•The estimated cost to bring to market a successful drug is now
$800 million!! (Dimasi, 2000)
neethu asokan

Drugs and the Discovery
Process
•Small Molecules
•Natural products
•fermentation broths
•plant extracts
•animal fluids (e.g., snake venoms)
•Synthetic Medicinal Chemicals
•Project medicinal chemistry derived
•Combinatorial chemistry derived
•Biologicals
•Natural products (isolation)
•Recombinant products
•Chimeric or novel recombinant products
neethu asokan

BASIC CONCEPT OF THE
DRUG MANAGEMENT CYCLE
neethu asokan
Management Support
Procurement
Planning
Distribution
Utilization
Storage

Advantages
Patients receive optimal pharmaceutical therapy
Enables consistent and predictable treatment from all
levels of providers and at all locations
Allows for improved availability of medicines because
of consistent and known usage patterns
Helps provide good outcomes because patients are
receiving the best treatment regimen available
Lowers cost
neethu asokan

Disadvantages
Inaccurate guidelines will provide the wrong information. Often
guidelines are based on existing practices rather than
evidenced-based medicine.
Guideline development and maintenance takes much time and
effort.
STGs may give false sense of security and discourage ongoing
critical thinking
neethu asokan

The biological targets of drug action
neethu asokan

•Medicine –a legal substance used to treat an illness or
ailment
•Side effects –an effect that accompanies the expected
effect of a drug
•Drug allergies –an unwanted effect that accompanies
the desired effect of a drug
•Overdose –a serious sometimes fatal reaction to a
large dose of a drug
•Dose –an exact amount of a drug
neethu asokan

Issues in Drug Discovery
•Hits and Leads -Is it a “Druggable” target?
•Resistance
•Pharmacodynamics
•Delivery -oral and otherwise
•Metabolism
•Solubility, toxicity
•Patentability
neethu asokan

Drug Discovery Without a Lead
Penicillins
1928 -Fleming
•mold spore contaminates culture dish
•left dish on bench top while on vacation
•weather was unseasonably cold
•particular strain of mold was a good penicillin producer
Bacteria lysed by green mold; could not reproduce effect -
serendipity.
Could not get penicillin in a useful clinical form
1940 -Florey (Oxford)
Succeeded in producing penicillin in a useful clinical form.
neethu asokan

Conclusion
•Cancer is common in all the ages and it shows metastasis,
angiogenesis and cell death, etc.
•So, drugs to cure cancer are necessary.
•Except toxicity, drugs are quite tolerable so they are combined
with other drugs.
•Comparative analysis of gene expression levels between drug
treated and non-treated condition should be studied.
•If getting superior quality drug than the available ones, clinical
trial phases can be performed on them.
neethu asokan